Combining with other weight loss agents Tesofensine + GLP-1 agonists (theoretical): Different mechanisms = potential synergy Tesofensine: Metabolic + CNS appetite GLP-1s : Strong appetite + gastric slowing Could enhance weight loss to 20-25%+ BUT: No clinical data, significant risks Not recommended without supervision Potential combination benefits: Address multiple pathways Overcome plateaus Better than either alone (theoretically) Metabolic boost + strong appetite suppression Maximum fat loss Combination risks: Compounded cardiovascular strain Unknown drug interactions Excessive weight loss risks Cost ($1,500-2,000/month) Safer alternatives to tesofensine combinations: Tirzepatide alone (15-22% loss, FDA approved) CagriSema (sema + cagrilintide, 15-25%) GLP-1 + lifestyle (safer, proven) Learn about peptide stacking strategies at SeekPeptides
Magnesium is important in the function of nerves, cells, bones, muscles and the heart, and when found in the body, it plays a key role in cellular energy production and DNA formation
These results provided the mechanistic foundation for developing CagriSema as a combination therapy targeting both amylin and GLP-1 pathways
A 2014 trial involving 475 patients with moderate to severe depression, most of whom were on SSRIs, found that no statistically significant differences among those who received 5-milligram folate supplements daily for three months and those who received a placebo
